BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 17413295)

  • 21. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
    Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.
    Passam AM; Zafiropoulos A; Miyakis S; Zagoreos I; Stavrianeas NG; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):302-9. PubMed ID: 16286054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
    Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
    J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
    Tiensiwakul P
    Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
    Zhu K; Shen Q; Ulrich M; Zheng M
    Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
    Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
    Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
    Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
    Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
    Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.
    Ramana GV; Vasanthi A; Khaja M; Su B; Govindaiah V; Jin L; Singh L; Chakraborty R
    J Genet; 2001 Dec; 80(3):137-40. PubMed ID: 11988632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
    Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
    Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
    Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
    Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
    Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
    Lima G; Soto-Vega E; Atisha-Fregoso Y; Sánchez-Guerrero J; Vallejo M; Vargas-Alarcón G; Llorente L
    Hum Immunol; 2007 Dec; 68(12):980-5. PubMed ID: 18191726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
    Szalai C; Duba J; Prohászka Z; Kalina A ; Szabó T; Nagy B; Horváth L; Császár A
    Atherosclerosis; 2001 Sep; 158(1):233-9. PubMed ID: 11500196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.